Literature DB >> 12887153

Protective effects of mustard leaf (Brassica juncea) against diabetic oxidative stress.

Takako Yokozawa1, Hyun Young Kim Kim, Eun Ju Cho, Noriko Yamabi, Jae Sue Choi.   

Abstract

Of four fractions (CH2Cl2, EtOAc, BuOH and H2O) from mustard leaf (Brassica juncea), the EtOAc fraction showed the strongest inhibitory effects, which were concentration-dependent, on the formation of advanced glycation end products and free radical-mediated protein damage in an in vitro system, indicating that this fraction has a potential protective role against diabetes and/or its complications. Based on these results, we carried out an in vivo study to determine whether the EtOAc fraction protected against diabetic oxidative stress induced by streptozotocin. Oral administration of the EtOAc fraction at doses of 50 and 200 mg/kg body weight/d for 10 d reduced the serum levels of glucose and glycosylated protein, implying that the impaired glucose metabolism due to diabetes had been ameliorated. In addition, the EtOAc fraction significantly reduced the thiobarbituric acid-reactive substance levels of serum and hepatic and renal mitochondria. Furthermore, the elevated levels of superoxide and nitrite/nitrate were reduced in a dose-dependent manner by oral administration of the EtOAc fraction. These findings suggest that the EtOAc fraction from mustard leaf might be beneficial in attenuating the damage caused by oxidative stress involved in diabetes and its complications.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12887153     DOI: 10.3177/jnsv.49.87

Source DB:  PubMed          Journal:  J Nutr Sci Vitaminol (Tokyo)        ISSN: 0301-4800            Impact factor:   2.000


  9 in total

1.  Antioxidants from defatted Indian Mustard (Brassica Juncea) protect biomolecules against in vitro oxidation.

Authors:  Anita Dua; Subhash Chander; Sharad Agrawal; Ritu Mahajan
Journal:  Physiol Mol Biol Plants       Date:  2014-08-15

2.  A pharmacological appraisal of medicinal plants with antidiabetic potential.

Authors:  Vasim Khan; Abul Kalam Najmi; Mohd Akhtar; Mohd Aqil; Mohd Mujeeb; K K Pillai
Journal:  J Pharm Bioallied Sci       Date:  2012-01

Review 3.  Dietary Phytochemicals: Natural Swords Combating Inflammation and Oxidation-Mediated Degenerative Diseases.

Authors:  Md Asiful Islam; Fahmida Alam; Md Solayman; Md Ibrahim Khalil; Mohammad Amjad Kamal; Siew Hua Gan
Journal:  Oxid Med Cell Longev       Date:  2016-09-19       Impact factor: 6.543

4.  Hypnotic Effect of Red Cabbage (Brassica oleracea) on Pentobarbital-Induced Sleep in Mice.

Authors:  Azar Hosseini; Mohammad-Ali Sobhanifar; Fatemeh Forouzanfar; Azita Aghaee; Hassan Rakhshandeh
Journal:  J Pharm Bioallied Sci       Date:  2018 Jan-Mar

5.  Anti-cancer activities of Brassica juncea leaves in vitro.

Authors:  Youngeun Kwak; Jungjae Lee; Jihyeung Ju
Journal:  EXCLI J       Date:  2016-11-15       Impact factor: 4.068

6.  The effects of Brassica juncea L. leaf extract on obesity and lipid profiles of rats fed a high-fat/high-cholesterol diet.

Authors:  Jae-Joon Lee; Hyun A Kim; Joomin Lee
Journal:  Nutr Res Pract       Date:  2018-07-18       Impact factor: 1.926

7.  Chemical Characterization of Three Accessions of Brassica juncea L. Extracts from Different Plant Tissues.

Authors:  Yassine Oulad El Majdoub; Filippo Alibrando; Francesco Cacciola; Katia Arena; Eleonora Pagnotta; Roberto Matteo; Giuseppe Micalizzi; Laura Dugo; Paola Dugo; Luigi Mondello
Journal:  Molecules       Date:  2020-11-19       Impact factor: 4.411

8.  Ayurvedic Herbal Preparation Supplementation Does Not Improve Metabolic Health in Impaired Glucose Tolerance Subjects; Observations from a Randomised Placebo Controlled Trial.

Authors:  Diederik Esser; Juri Matualatupauw; Ric C H de Vos; Ron Wehrens; Jos van der Stappen; Ingrid van der Meer; Lydia A Afman
Journal:  Nutrients       Date:  2021-01-18       Impact factor: 5.717

9.  Red Cabbage (Brassica oleracea) Ameliorates Diabetic Nephropathy in Rats.

Authors:  Hazem A H Kataya; Alaaeldin A Hamza
Journal:  Evid Based Complement Alternat Med       Date:  2008-09       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.